Researchers found that certain bacteria might be engineered to help fight cancer more effectively. Specifically, scientists are exploring the use of Clostridium sporogenes, a type of anaerobic bacteria that thrives in low-oxygen environments like those found in tumors. Unlike healthy tissues, which are well-oxygenated, tumors often have poorly oxygenated areas that these bacteria can target. By injecting dormant spores of C. sporogenes, doctors hope to create localized infections in tumors that could suppress their growth without harming surrounding healthy cells.

This approach could revolutionize cancer treatment for people seeking effective therapies with fewer side effects. Current treatments like chemotherapy and radiation often damage healthy cells, leading to unpleasant side effects. If successful, bacterial therapies could provide a more targeted method, potentially improving outcomes for cancer patients. Early studies have shown some tumor regression in patients treated with C. sporogenes, but the effects were limited, as the bacteria struggled to reach the outer rim of tumors.

The research is still in its early stages, focusing on genetic engineering to enhance the bacteria’s ability to tolerate oxygen and improve its tumor-targeting capabilities. Scientists are working on creating engineered variants of C. sporogenes that can penetrate deeper into tumors and only activate under specific conditions. While this research shows promise, it is important to note that it is still in the experimental phase, and further studies will be necessary to determine its effectiveness in humans.

Original source